Historical record - last NADAC effective date: 8/21/2024
Product Information
FOSAPREPITANT 150 MG VIAL is a generic product labeled by Camber Pharmaceuticals Inc., priced at $38.5080 per EA under NDC 31722016531. Its NADAC has been published 35 times since Aug 21, 2024.
FDA first approved this application on Jul 29, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
150 mg/5mL
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722016531
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
8/21/2024
Active Ingredients
FOSAPREPITANT DIMEGLUMINEApproval Type
Generic (ANDA)
FDA Application
ANDA214616FDA Approved
7/29/2021
TE Code
AP
On Market Since
7/29/2021
Pharmacological Classes
Price Statistics
The NADAC for FOSAPREPITANT 150 MG VIAL has been published 35 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $38.5080 per EA |
|---|---|
| All-time high | $38.5080 (Apr 16, 2025) |
| All-time low | $38.5080 (Aug 21, 2024) |
| Median price | $38.5080 |
| Average price | $38.5080 |
| Largest weekly change | 0.0% (Aug 28, 2024) |
| Weeks tracked | 35 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Apr 16, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FOSAPREPITANT 150 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FOSAPREPITANT 150 MG VIAL, manufactured by Camber Pharmaceuticals Inc., is $38.5080 per EA (NDC 31722016531), effective Apr 16, 2025.
How has the price of FOSAPREPITANT 150 MG VIAL changed over time?
Over the history we have for it, the NADAC for FOSAPREPITANT 150 MG VIAL has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for FOSAPREPITANT 150 MG VIAL?
Since Aug 21, 2024, the NADAC for FOSAPREPITANT 150 MG VIAL has ranged from a low of $38.5080 (Aug 21, 2024) to a high of $38.5080 (Apr 16, 2025), with a median of $38.5080 per EA.
Are there cheaper alternatives to FOSAPREPITANT 150 MG VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FOSAPREPITANT 150 MG VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures FOSAPREPITANT 150 MG VIAL?
FOSAPREPITANT 150 MG VIAL (NDC 31722016531) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.